The EDAN SE-18 and the Push for Earlier Cardiac Detection


EDAN SE-18 18-Lead ECG Workstation

China’s medical device sector is increasingly competing on diagnostic precision. The EDAN SE-18 18-lead ECG workstation represents a strategic bet on early detection of posterior and right ventricular myocardial infarction.

Standard 12-lead electrocardiographs remain the global baseline for cardiac assessment, but they miss a meaningful portion of ischemic events. The EDAN SE-18 extends coverage to 18 leads, enabling real-time sampling of the posterior and right ventricular walls—areas often overlooked in routine diagnostics.

This is not a niche upgrade. In emergency and cardiology settings, the SE-18’s broader lead configuration directly reduces the likelihood of missed myocardial infarctions. Its built-in ST-view analysis and advanced tools like vectorcardiography and signal-averaged ECG provide clinicians with a more layered picture of cardiac electrical activity.

Operationally, the device targets friction points in hospital workflows. Paperless reporting, on-screen measurement, and a configurable touchscreen interface reduce turnaround time between acquisition and interpretation. The color-coded plug-and-play lead wires and signal quality LEDs minimize setup errors in high-pressure environments.

EDAN, a Shenzhen-based manufacturer, has built its reputation on electrocardiography and patient monitoring. The SE-18 sits within a broader product ecosystem that includes defibrillators and ultrasound systems, allowing hospitals to standardize procurement across diagnostic modalities.

From a supply chain perspective, the SE-18 reflects China’s growing capability in producing higher-complexity medical electronics—devices that integrate precision signal acquisition with embedded diagnostic software. This is a segment where domestic players are gradually displacing legacy imports from GE, Philips, and Schiller.

For hospitals expanding cardiac care capacity, the SE-18 offers a path to upgrade diagnostic fidelity without overhauling existing digital infrastructure.

Why it matters:
The SE-18 is a signal of two trends: the migration of advanced cardiac diagnostics from specialized centers to general hospitals, and the maturation of China’s medical device industry into higher-value, algorithm-driven equipment.


View Product →


ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.

Follow ScientificChina for deeper insight into the infrastructure behind global innovation.

Visit ScientificChina.

Home Shop Cart Account
Shopping Cart (0)

No products in the cart. No products in the cart.